Sudhir Agrawal

Sudhir Agrawal D.Phil, FRSC is the Founder and President of ARNAY Sciences since October 2017 and serves as Co-Founder and scientific advisor at Aldebaran Therapeutics while holding the position of Chairman of the Scientific Advisory Board for Genetic Medicines at Alloy Therapeutics, Inc. Additionally, Sudhir Agrawal is a member of several scientific advisory boards, including QurAlis, Dyne Therapeutics, SynGenis, and HAYA Therapeutics SA. Sudhir Agrawal is also a Scientific Advisor at Bolden Therapeutics and an Affiliate and Visiting Professor in the Department of Medicine at UMass Chan Medical School. Sudhir Agrawal completed post-doctoral research in Nucleic Acids at the MRC Laboratory of Molecular Biology, Cambridge, UK, and holds an M.Sc and D.Phil. in Organic Chemistry from Allahabad University, India.